You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 20, 2025

Drug Price Trends for PREDNISOLONE AC


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for PREDNISOLONE AC

Average Pharmacy Cost for PREDNISOLONE AC

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
PREDNISOLONE AC 1% EYE DROP 61314-0637-05 4.86804 ML 2025-06-18
PREDNISOLONE AC 1% EYE DROP 61314-0637-10 4.87125 ML 2025-06-18
PREDNISOLONE AC 1% EYE DROP 60758-0119-15 4.71602 ML 2025-06-18
PREDNISOLONE AC 1% EYE DROP 61314-0637-15 4.71602 ML 2025-06-18
PREDNISOLONE AC 1% EYE DROP 60758-0119-05 4.86804 ML 2025-06-18
PREDNISOLONE AC 1% EYE DROP 70748-0332-04 4.71602 ML 2025-06-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Prednisolone Acetate

Introduction to Prednisolone Acetate

Prednisolone acetate is a synthetic corticosteroid used in various medical applications, particularly in ophthalmic and other therapeutic areas. It is known for its anti-inflammatory and immunosuppressive properties, making it a crucial component in the treatment of allergies, conjunctivitis, iritis, and postoperative ocular inflammation[2][5].

Market Overview

The global prednisolone acetate market is characterized by its fragmented nature, with several key players competing for market share. Companies such as Sanofi, Symbiotec Pharma Lab Pvt., Wuhan DKY Technology, and Henan Lihua Pharmaceutical are among the top vendors in this market[1].

Market Drivers and Restraints

Drivers

  • Increasing Demand for Ophthalmic Treatments: The rising incidence of eye disorders and the need for effective treatments drive the demand for prednisolone acetate. Its efficacy in treating allergic conjunctivitis and other ocular inflammations makes it a preferred choice among healthcare providers[2][5].
  • Expanding Applications: Beyond ophthalmic use, prednisolone acetate is used in various other applications, including injections and ointments, which broadens its market scope[3][4].
  • Technological Advancements: Improvements in manufacturing processes and the development of new formulations are expected to enhance the market growth[4].

Restraints

  • Regulatory Challenges: Strict regulatory requirements and the need for compliance with various international standards can act as barriers to entry for new players and affect the overall market growth[1][4].
  • Economic Factors: The COVID-19 pandemic has had a significant impact on the global economy, affecting production, supply chains, and financial markets. This could lead to volatility in the market[1].
  • Competition: The highly competitive nature of the market, with multiple players offering similar products, can lead to price competition and affect profit margins[1].

Market Segmentation

By Type

  • Prednisolone Acetate: This is the most common form of prednisolone used in ophthalmic suspensions and other applications[1][3].
  • Methylprednisolone: Although not as widely used as prednisolone acetate, methylprednisolone is another type of corticosteroid that competes in the market[3].

By Application

  • Ophthalmic Solutions and Suspensions: These are the primary applications of prednisolone acetate, used to treat various eye conditions[2][5].
  • Injections and Ointments: Prednisolone acetate is also used in injectable and topical forms for treating other inflammatory conditions[3].

By Geography

  • North America: This region is a significant market due to the high prevalence of eye disorders and the presence of major pharmaceutical companies[1][3].
  • Europe: Europe is another key market with a strong demand for ophthalmic treatments[1][4].
  • Asia-Pacific: This region is expected to show rapid growth due to increasing healthcare spending and a large patient population[1][3].

Price Projections

Current Pricing

  • The cost for prednisolone ophthalmic acetate 1% ophthalmic suspension can range from $54 to $178 for a 5-milliliter supply, depending on the brand and pharmacy[2][5].

Future Trends

  • The market is expected to experience significant growth from 2023 to 2031, driven by increasing demand and technological advancements. However, prices may remain volatile due to economic factors and competition[1][3].
  • The average price of prednisolone acetate is expected to stabilize as the market becomes more competitive, with generic versions becoming more widely available[2][5].

Impact of COVID-19

The COVID-19 pandemic has had a multifaceted impact on the prednisolone acetate market. It affected production and supply chains, leading to potential shortages and price fluctuations. However, the pandemic also highlighted the importance of effective treatments for various health conditions, including eye disorders, which could drive long-term demand for prednisolone acetate[1].

Competitive Landscape

The market is highly competitive, with key players employing various strategies such as partnerships, new product launches, and expansions to increase their market share. Companies like Sanofi and Henan Lihua Pharmaceutical are among the leaders in this space[1].

Key Players

  • Sanofi: Known for its extensive portfolio of pharmaceutical products, including prednisolone acetate.
  • Symbiotec Pharma Lab Pvt.: A significant player in the production of prednisolone acetate and other pharmaceuticals.
  • Wuhan DKY Technology: Specializes in the development and manufacturing of various pharmaceutical products, including prednisolone acetate.
  • Henan Lihua Pharmaceutical: A major manufacturer of prednisolone acetate and other corticosteroids[1].

Market Forecast

The prednisolone acetate market is projected to experience robust growth from 2023 to 2031. Here are some key projections:

  • Market Size: The market is expected to grow significantly, driven by increasing demand for ophthalmic treatments and other applications.
  • Geographical Growth: Asia-Pacific is anticipated to be a high-growth region due to increasing healthcare spending and a large patient population.
  • Price Stability: As the market becomes more competitive, prices are expected to stabilize, with generic versions playing a crucial role[1][3].

Conclusion

The prednisolone acetate market is poised for significant growth driven by its efficacy in treating various health conditions, particularly ophthalmic disorders. Despite challenges such as regulatory hurdles and economic volatility, the market is expected to expand due to technological advancements and increasing demand.

Key Takeaways

  • Growing Demand: Increasing incidence of eye disorders and other inflammatory conditions drives the demand for prednisolone acetate.
  • Market Competition: The market is highly competitive, with key players using various strategies to increase their market share.
  • Price Volatility: Prices may fluctuate due to economic factors and competition, but are expected to stabilize with the rise of generic versions.
  • Geographical Expansion: Asia-Pacific is expected to be a high-growth region due to increasing healthcare spending.
  • Technological Advancements: Improvements in manufacturing processes and new formulations will enhance market growth.

FAQs

Q: What are the primary applications of prednisolone acetate?

  • Prednisolone acetate is primarily used in ophthalmic solutions and suspensions to treat conditions such as allergic conjunctivitis, iritis, and postoperative ocular inflammation[2][5].

Q: Who are the key players in the prednisolone acetate market?

  • Key players include Sanofi, Symbiotec Pharma Lab Pvt., Wuhan DKY Technology, and Henan Lihua Pharmaceutical[1].

Q: How has the COVID-19 pandemic affected the prednisolone acetate market?

  • The pandemic has affected production and supply chains, leading to potential shortages and price fluctuations. However, it has also highlighted the importance of effective treatments, driving long-term demand[1].

Q: What is the expected market growth for prednisolone acetate from 2023 to 2031?

  • The market is expected to experience significant growth driven by increasing demand and technological advancements[1][3].

Q: Are generic versions of prednisolone acetate available?

  • Yes, generic versions of prednisolone acetate are available, which can affect pricing and market competition[2][5].

Sources

  1. PharmiWeb: Prednisolone acetate Market 2021-Share, Industry Analysis, Top Leading Companies And Sellers Covered Worldwide, Industry Growth Forecast Through 2029.
  2. Drugs.com: Prednisolone ophthalmic Prices, Coupons, Copay Cards & Patient Assistance.
  3. Market Research Intellect: Global API use Prednisolone Market Size, Trends and Projections.
  4. MarketPublishers: Prednisolon Acetate (CAS 52-21-1) Market Research Report 2024.
  5. Drugs.com: Pred Forte Prices, Coupons, Copay Cards & Patient Assistance.
Last updated: 2024-12-30

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.